Literature DB >> 6478650

Circulating human C-reactive protein binds very low density lipoproteins.

I F Rowe, A K Soutar, I M Trayner, G R Thompson, M B Pepys.   

Abstract

Native human CRP in solution formed complexes with the abnormal lipoprotein beta-VLDL in serum of patients with type III hyperlipoproteinaemia. CRP also formed complexes in sera from individuals with type IV and type V hyperlipoproteinaemia. The binding was calcium-dependent and inhibitable by free phosphoryl choline. No complexes were demonstrable in sera containing high LDL levels from cases of type IIa hyperlipoproteinaemia. Addition of isolated beta-VLDL, but not of isolated LDL, to acute phase normolipoproteinaemic serum caused the appearance of soluble CRP-lipoprotein complexes. In contrast, addition of an excess of isolated normal VLDL to acute phase serum or to isolated CRP was followed by agglutination (creaming) of the lipoprotein particles. Rabbit CRP, on the other hand, formed soluble complexes both with normal human apoB containing lipoproteins and with the abnormal beta-VLDL. Human CRP complexed with rabbit beta-VLDL but not with normal rabbit serum lipoproteins. These interactions may be important for the role of CRP in health and disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478650      PMCID: PMC1576975     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Comparison between the use of isopropanol and tetramethylurea for the solubilisation and quantitation of human serum very low density apolipoproteins.

Authors:  L Holmquist; K Carlson; L A Carlson
Journal:  Anal Biochem       Date:  1978-08-01       Impact factor: 3.365

2.  Changes in apolipoproteins and properties of rabbit very low density lipoproteins on induction of cholesteremia.

Authors:  V G Shore; B Shore; R G Hart
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

3.  Analogues in other mammals and in fish of human plasma proteins, C-reactive protein and amyloid P component.

Authors:  M B Pepys; A C Dash; T C Fletcher; N Richardson; E A Munn; A Feinstein
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

4.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

5.  Comparative studies on the binding properties of human and rabbit C-reactive proteins.

Authors:  E B Oliveira; E C Gotschlich; T Y Liu
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  Lipoprotein electrophoresis in fat embolism: a preliminary report.

Authors:  N Treiman; V Waisbrod; H Waisbrod
Journal:  Injury       Date:  1981-09       Impact factor: 2.586

7.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

8.  Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.

Authors:  M B Pepys; A C Dash; R E Markham; H C Thomas; B D Williams; A Petrie
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

9.  Interaction of C-reactive protein with artificial phosphatidylcholine bilayers.

Authors:  J E Volanakis; K W Wirtz
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

10.  Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species.

Authors:  R W Mahley; T L Innerarity; M S Brown; Y K Ho; J L Goldstein
Journal:  J Lipid Res       Date:  1980-11       Impact factor: 5.922

View more
  15 in total

1.  Membrane curvature recognition by C-reactive protein using lipoprotein mimics.

Authors:  Min S Wang; Reid E Messersmith; Scott M Reed
Journal:  Soft Matter       Date:  2012-08-14       Impact factor: 3.679

2.  Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease.

Authors:  S M Jones; C P Harris; J Lloyd; C A Stirling; J P Reckless; N J McHugh
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 3.  Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.

Authors:  Imran Bhutto; Gerard Lutty
Journal:  Mol Aspects Med       Date:  2012-04-21

4.  Bruch's Membrane and the Choroid in Age-Related Macular Degeneration.

Authors:  Malia Edwards; Gerard A Lutty
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  C reactive protein and immunoglobulin G in synovial fluid and serum in joint disease.

Authors:  B Shine; J T Bourne; F Begum Baig; J Dacre; D V Doyle
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

6.  C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases.

Authors:  P Vaith; G M Hänsch; H H Peter
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer.

Authors:  Azubuike I Okemefuna; Lasse Stach; Sudeep Rana; Akim J Ziai Buetas; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

8.  Plasma lipids and lipoproteins in juvenile chronic arthritis.

Authors:  A Bakkaloglu; B Kirel; S Ozen; U Saatçi; N Beşbaş
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

9.  Monoclonal phosphorylcholine antibody binds to beta-lipoprotein from different animal species.

Authors:  U B Sørensen
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

10.  Plasma protein insudation as an index of early coronary atherogenesis.

Authors:  Y Zhang; W J Cliff; G I Schoefl; G Higgins
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.